Arkolith/Insider Trading/TENX/Form 4

Giordano Christopher Thomas

CEO, DirectorTENAX THERAPEUTICS, INC. (TENX) · full profile →Form 4 · filed Jul 14, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 13, 2026Option exercise(M)219$3.55$7773K
Jul 13, 2026Option exercise(M)9K$5.94$50K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 13, 2026Option exercise(M)219—$0218
Jul 13, 2026Option exercise(M)9K—$01.2M

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-303600) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML